Journal Publications

I. Research artıcles

  1. şumnu, m., çalış, s., sarıkaya, y., hıncal, a.a., "bazı antasit maddelerin yüzey alanlarının saptanması", hac. üniv. ecz. fak. der., 4(2) 57-63, 1984.
  2. çalış, s., şumnu, m., hıncal, a.a.,  "ın vitro adsorption of propranolol hydrochloride by various antacids",  drug dev. ınd. pharm., 12(11-13), 1833 - 1845, 1986.
  3. çapan, y., şenel, s., çalış, s.,  takka, s., hıncal, a.a., "formulation and ın vitro-ın vivo evaluations on sustained release acetylsalicylic acid tablets",  pharm. ınd.,51 (4), 443-448, 1989.
  4. çalış, s., çalış, ü., şumnu, m., hıncal, a.a., "colorimetric determination of a novel antimicrobial surfactant mixture (c31g)", doğa - tr. j. pharmacy,  1, 97-102, 1991. 
  5. ünlü, n., çalış, s., şumnu, m., hıncal, a.a., "evaluation of the ınterfacial properties of a new potent antimicrobial surfactant-c31g", boll.chim farmaceutico, 130 (6) , 234-238, 1991.
  6. çalış, s., yuluğ, n., şumnu, m., ayhan, a., hıncal, a.a., "a non-antibiotic  antimicrobial mixture (c31g) : evaluation of the antimicrobial efficiency of c31g on vaginal cultures",  boll. chim. farmaceutico, 131 (9), 335-338, 1992.
  7. ünlü, n., çalış, s., irkeç, m., aksoy, f., orhan, m., şumnu, m., hıncal, a.a., "evaluation of the ırritation of a new potent antimicrobial surfactant - c31g: an ırrigation study on rabbit eyes", s.t.p. pharma sciences,  special ıssue on  ocular  administration-janvier-fevrier 2 (1), 45 – 48, 1992.
  8. çalış, s., şumnu, m., hıncal, a.a., "effect of suppository bases on the release properties of a potent antimicrobial agent (c31g)", pharmazie, 49, h.5.336-339, 1994.
  9. mehta, r.c., jeyanthi, r., çalış, s., thanoo, b.c., burton, k.w., deluca, p.p., "biodegradable microspheres as depot system for parenteral delivery of peptide drugs", j. control. rel., 29, 375-384, 1994.
  10. çalış, s., jeyanthi, r., tsai, t., mehta, r.c., deluca, p.p., "adsorption of salmon  calcitonin to plga microspheres",  pharm res.,12 (7), 1072-1076, 1995.
  11. bozdağ, s., çalış, s., şumnu, m., "formulation and stability evaluation of enteric coated omeprazole formulations", stp pharm. sci., 9(4), 321-327, 1999.
  12. çalış, s., bozdağ, s., kaş, s., hıncal, a. a. “formulation and characterization of albumin microspheres containing naproxen sodium”, j. control. rel. (special ıssue), 64, 269-271, 2000.
  13. tunçay, m., çalış, s., kaş, h.s., ercan, m.t., peksoy, i., hıncal, a.a., "diclofenac sodium ıncorporated plga (50:50) microspheres: formulation considerations and ın vitro/ın vivo evaluation", ınt. j. pharm., 195 (1-2) 179-188, 2000.
  14. tunçay, m., çalış, s., kaş, h.s., ercan, m. t., peksoy, i., hıncal, a.a., "ın vitro and ın vivo evaluation of diclofenac sodium loaded albumin microspheres", j. microencapsulation, 17 (2) 145-156, 2000.
  15. yenice, i., çalış, s., çapan, y., "quality control of conventional and controlled-release carbamazepine tablets available ın turkish market", hacettepe university journal of the faculty of pharmacy, 20 (2),  45-52,  2000.  (in turkish)
  16. doğru, t., çaliş, s., öner, f., "oral multiple w/o/w emulsion formulation and in vitro/in vivo evaluation of a peptide salmon calcitonin", j. clin. pharm. ther., 25(6), 435-443, 2000.
  17. bozdağ, s., çaliş, s., kaş, h.s., ercan, m.t., peksoy, i., hincal, a.a., "in vitro evaluation and intraarticular administration of poly (d,l-lactide-co-glycolide) microspheres containing naproxen sodium",  j. microencapsulation, 18(4), 443-456, 2001.
  18. doğru, t., çaliş, s., öner, f., salmanoğlu, b., alpar, r., hincal, a.a., "evaluation of oral delivery of salmon calcitonin using w/o/w multiple emulsion formulation" j.control.rel. (special lssue), 72 (1-3), 293-295, 2001.
  19. çaliş, s., öner, f., kaş, s., hincal, a.a., "approaches to education of pharmaceutical biotechnology in faculties of pharmacy: current status and future needs" curr. pharm. biotech, 2 (2), 143-155, 2001.
  20. çalış, s., bozdağ, s., kaş, h.s., tunçay, m., hıncal, a.a., “ınfluence of ırradiation sterilization on poly(lactide-co-glycolide) microspheres containing antiinflammatory drugs”  ıl farmaco, 57, 55-62, 2002.
  21. arıca, b., çalış, s., kaş, h.s., sargon, m.f., hıncal, a.a., "5-fluorourasil encapsulated alginate beads for the treatment of breast cancer" ınt. j. pharm., 242, 267-269, 2002.
  22. yenice, i., çalış, s., kaş, h.s., özalp, m., ekizoğlu, m., hıncal, a.a., "biodegradable ımplantable teicoplanin beads for the treatment of bone ınfections" ınt. j. pharm., 242, 271-275, 2002.
  23. dodov, m.g., kumbaradzı, e.f., çalış, s., goracınova, k., mladenovska, k., sımonoska, m., hıncal, a.a. ”biopharmaceutical characterization of topical liposome formulations bearing 5-fu”, maced pharm bull, 48(1,2) 21-24, 2002.
  24. yenice i., çalış, s., atilla, b., kaş, h.s., özalp, m., ekizoğlu, m., bilgili, h., hıncal, a.a., “ın vitro/ın vivo evaluation of the efficiency of teicoplanin loaded biodegradable microparticles formulated for ımplantation to ınfected bone defects” j. microencapsulation, 20(6), 705-17, 2003.
  25. dodov, m.g., kumbaradzı, e.f., goracınova, k., çalış, s., sımonoska, m., hıncal, a.a. “5-fluorouracil in topical liposome gels for anticancer treatment - formulation and characterisation” acta pharmaceutica, 53, 241-250, 2003.
  26. dodov, m.g., çalış, s., goracınova, k., kumbaradzı, e.f. “liposomes as biodegradable carriers of 5-fu – formulation and characterisation” macedonian pharmaceutical bulletin, 49 (1-2), 21-22, 2003.
  27. dodov, m.g., kumbaradzı, e.f., goracınova, k., mladenovska, k., sımonoska, m., çalış, s., hıncal, a.a. “formulation variables, encapsulation efficiacy and drug release from 5-fu loaded liposomes stabilised by lyophilisation” macedonian pharmaceutical bulletin, 49 (1-2), 36-37, 2003.
  28. şamdancıoğlu, s., çalış, s., kır, s., şumnu, m., “the determination of alendronate sodium ın microparticular systems by high performance liquid chromatography” fabad  j. pharm. sci., 28(4), 183-192, 2003.
  29. sayın, b., çalış, s. “ ınfluence of accelarated storage conditions on the stability of vancomycin loaded poly(d,l-lactide-co- glycolide) microspheres” fabad j. pharm. sci. 29(3), 111-116, 2004.
  30. dodov, m.g., kumbaradzı, e.f., çalış, s., goracınova, k., mladenovska, k., sımonovska, m., hıncal, a.a., “formulation and characterisation of 5-fluorouracil loaded liposomes” bulletin of the chemists and technologists of macedonia, 23(1), 13-18, 2004.
  31. arıca, b., çalış, s., atilla, p., durlu, t., çakar, n., kaş, h.s., hıncal, a.a. “ın vitro and ın vivo studies of ıbuprofen loaded biodegradable alginate beads” j. microencapsulation, 22(2), 153-165, 2005.
  32. çırpanlı, y., ünlü, n., çalış, s., hıncal, a.a. “formulation and ın vitro characterization of retinoic acid loaded poly(lactic-co-glycolic acid) microspheres” j. microencapsulation 22(8): 877–889, 2005.
  33. şamdancıoğlu, s., çalış, s., şumnu, m., hıncal, a.a. “formulation and ın vıtro evaluation of bisphosphonate loaded microspheres for ımplantation ın osteolysis”  drug dev. ınd. pharm. 32, 473-481, 2005.
  34. şamdancıoğlu, s., çalış, s., şumnu, m., hıncal, a.a. “ın vıtro studies on alendronate sodium ıncorporated biodegradable alginate beads for ımplantation” fabad j. pharm. sci. 30, 142-149, 2005.
  35. glavas-dodov, m., fredro-kumbaradzi, e., goracinova, k., simonoska, m. s., çalış, trajkovic-jolevska, s., hıncal, a.a. “the effects of lyophilization on the stability of liposomes containing 5-fu” ınt. j. pharm., 291:79–86, 2005.
  36. sayın, b., çalış, s., atilla, b., marangoz, s., hıncal, a.a. “ın vitro – ın vivo characterization of vancomycin – ımpregnated and vancomycin - loaded microspheres blended with human / rabbit bone grafts” j. microencapsulation 23(5): 553–566, 2006.
  37. bilensoy, e., çırpanlı, y., şen, m., doğan, a.l., çalış, s. “thermosensitive mucoadhesive gel formulation loaded with 5-fu:cyclodextrin complex for hpv-ınduced cervical cancer” j. ıncl. phenom. macrocycl. chem., 57:363–370, 2007.
  38. glavas-dodov, m., hıncal, a.a., çalış, s., simonoska, m. s., n.geskovskı, goracinova, k., “spray-dried chitosan-ca-alginate microparticles for colon delivery of 5-fu“, maced. pharm bull,53 (1,2), 45-46, 2007.
  39. sarısözen, c., arıca, b., hıncal, a.a., çalış, s. “development of biodegradable drug releasing polymeric cardiovascular stents and ın vitro evaluation” j. microencapsulation, 26(6), 501–512, 2009.
  40. çırpanlı, y., bılensoy, e., doğan, a.l., çalış, s. “comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery” eur. j. pharm. biopharm., 73(1), 82-9, 2009.
  41. çakmak, a., çırpanlı, y., bılensoy, e., yorgancı, k., çalış, s., sarıbaş, s., kaynaroğlu, v. “antibacterial activity of triclosan chitosan coated graft on hernia graft ınfection model” ınt. j. pharm., 381(2), 214-219, 2009.
  42. glavas-dodov, m., çalış, s., crcarevska, m.s., geskovskı, n., petrovska, v., goracinova, k. “wheat germ agglutinin conjugated chitosan-ca-alginate microparticles for local colon delivery of 5-fu: development and ın vitro characterization” ınt. j. pharm., 381(2), 166-75, 2009.
  43. bılensoy, e., moroy, p., çırpanlı, y., bılensoy, t., çalış, s., mollamahmutoglu, l. “a double-blind placebo-controlled study of 5-fluorouracil:cyclodextrin complex loaded thermosensitive gel for the treatment of hpv ınduced condyloma” j. ıncl. phenom. macrocycl. chem., 57, 363–370, 2010.
  44. sarısözen, c., arıca, b., orman, m.n., hıncal, a.a., çalış, s. “optimization of prednisolone acetate loaded chitosan microspheres using a 23 factorial design for preventing restenosis” drug delivery, 17(3), 178-86, 2010.
  45. çırpanlı, y., robıneau, c., çapan, y., çalış, s. “etodolac loaded poly(lactide-co-glycolide) nanoparticles: formulation and ın vitro characterization” hacettepe üniversitesi eczacılık fakültesi dergisi, 29(2), 105-114, 2009. (pressed in 2010).
  46. sımonoska crcarevska, m., glavas dodov, m., calıs, s., petrovska, v., tonıc rıbarska, j., goracınova, k. “physico-chemical characterization of biodegradable polymeric nanoparticles loaded with cpt-11” arhiv za farmaciju, 60(5), 746, 2010.
  47. çırpanlı, y., yerlikaya, f, ozturk, k., erdoğar, n., launay, m, gegu, c., leturgez, t., bilensoy, e., çalış, s., çapan, y. “comparative evaluation of ın vitro parameters of tamoxifen citrate loaded chitosan, poly(ε-caprolactone) and poly(lactide-co-glycolide) nanoparticles” pharmazie, 65: 867-870, 2010.
  48. çırpanlı, y., allard, e., passıranı, c., bılensoy, e., lemaıre, l., çalış, s., benoıt, j.p. “antitumoral activity of camptothecin-loaded nanoparticles ın 9l rat glioma model”, ınt. j. pharm. 403(1-2), 201-206, 2011.
  49. çırpanlı, y., bozdag-pehlivan, s., ekizoglu, m., bodur, e., ozalp, m., çalış, s. “ın vitro evaluation of vancomycin microspheres ın serratiopeptidase loaded thermosensitive gel for the treatment of bacterial biofilm” european journal of pharmaceutical sciences , 44, supplement: 1, 155-156, 2011.
  50. crcarevska, m. simonoska; dodov, m. glavas; calis, s. ‘‘modified nanoprecipitation method for incorporation of hydrophilic drug substances into amphiphilic plga nanocarriers’’ european journal of pharmaceutical sciences , 44, supplement: 1, 140-141, 2011.
  51. kılıç, m. a., ozlu, e., çalış, s., "a novel protein-based anticancer drug encapsulating nanosphere: apoferritin-doxorubicin complex" journal of biomedical nanotechnology, 8, 1-7, 2011.
  52. geskovskı n, kuzmanovska s., crcarevska ms, calıs s, dımchevska s, petrusevska m, zdravkovskı p, goracınova k, comparative biodistribution studies of technetium-99m radiolabeled amphiphilic nanoparticles using three different reducing agents during the labeling procedure, j. label compd. radiopharm, 56, (14), 689-695, 2013.
  53. simonoska c.m, geskovski n, calis s, dimchevska s, kuzmanovska s, petruševski g, kajdžanoska m, ugarkovic s, goracinova k., ‘‘definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded plga/peo-ppo-peo nanoparticles using ofat experiments’’ eur j pharm sci. 49(1):65-80,2013.
  54. harika öcal, betül arica-yegin, imran vural, katerina goracinova, sema çaliş, 5-fluorouracil-loaded pla/plga peg-ppg-peg polymeric nanoparticles: formulation, in vitro characterization and cell culture studies, drug development and industrial pharmacy, 40(4), 560-7, 2014.
  55. yağ, g., çaliş, s., arica, b., "the effect of inorganic salt type and concentration on hydrophilic drug loading into microspheres using the emulsion/solvent diffusion method" drug development and industrial pharmacy, 40(3), 390-7, 2014.
  56. oztürk k, ertürk as, sarısözen c, tulu m, calış s., cytotoxicity and in vitro characterization studies of synthesized jeffamine-cored pamam dendrimers, j microencapsul. 3 (2); 127-136, 2014.

II. Chapters ın books

  1. ÇALIŞ, S., ŞUMNU, M., HINCAL, A.A., "In Vitro Adsorption of Propranolol Hydrochloride by Various Antacids", Pharmaceutical Technology, Controlled Drug Release, Volume I  Kitabında 12. Bölüm. Editör: H. Rubinstein, Ellis Horwood Ltd., Sussex, 1987.
  2. ÇALIŞ, S., JEYANTHİ, R., MEHTA, R.C., DELUCA, P.P., "Development of A Controlled Peptide Delivery System: Release Behavior of sCT from PLGA Microspheres of Different Matrix Characteristics", Minutes, 9th International Symposium on Microencapsulation s.45 Editörler: H.Süheyla Kaş, A.Atilla Hıncal, Editions de Sante, Paris, 1993. 
  3. HIncal, A.A., Şenel, S, ÇALIŞ, S., Apİkoğlu, Ş., "Presentation of the Responses to the EAFP Questionnaire on Developing Teaching Objectives in Pharmaceutical  Technology" in Bourlioux, P., Hıncal, A.A., Şenel, S., Florence, A.T.,(Eds), Emerging Themes andTechnologies in Pharmacy   Education, Şafak Press, s.30-37, Ankara, 1997.
  4. HINCAL, A.A., ÇALIŞ, S., “Microsphere Preparation by Solvent Evaporation Process” In: Handbook of Pharmaceutical Controlled Release Technology, Wise L. D. (Ed), Mercel Dekker Inc. 2000.
  5. ARICA, B., ÇALIŞ, S., KAŞ, H.S., HINCAL, A.A., "Chitosan Treated 5-FU Liposomes: Preparation and In Vitro Evaluation" in Minutes, New Trends in Polymers for Oral and Parenteral Administration, s. 225-228, Eds; Barratt, G., Duchene, D., Fattal, F., Legtendre, J.Y., Editions de Sante, Paris, 2001.
  6. YENİCE, İ., ÇALIŞ, S., KAŞ, S., ÖZALP, M., EKİZOĞLU, M., HINCAL, A.A., "Teicoplanin (A  Glycopeptide Antibiotic) Loaded Biodegradable Microparticulate System: Formulation Considerstions and In Vitro Evaluation" in Minutes, New Trends in Polymers for Oral and Parenteral Administration, s. 305-308 , Eds; Barratt, G., Duchene, D., Fattal, F., Legtendre, J.Y., Editions de Sante, Paris, 2001.
  7. ÇALIŞ, S., ARICA, B., KAŞ, H.S., HINCAL, A.A., "Evaluation of 5-Fluorouracil/ Alginate Microspheres in Chitosan Gel for Local Therapy in Breast Cancer" in Chitosan in Pharmacy and Chemistry, p. 65-69, R.A.A. Muzzarelli and C. Muzzarelli, (Eds) Atec, Italy, 2002.
  8. ARICA, B., ÇALIŞ, S., KAŞ, H.S., HINCAL, A.A."Chitosan Microspheres of Ibuprofen: Evaluation and In Vitro Characterization" in Chitosan in Pharmacy and Chemistry, p. 71-76,  R.A.A. Muzzarelli and C. Muzzarelli  (Eds) Atec, Italy, 2002.
  9. ÇALIŞ, S., VURAL, İ., "Phase Diagrams, Interfacial Phenomena and Surface Activity" (Chapter  3)  in  Pharmaceutical Technology, p.27-39, Ayla Z. Gürsoy (Ed), Piksel Bilişim Press, İstanbul 2004.  [Textbook,. in Turkish]
  10. ÇALIŞ, S. “Medical Devices and Pharmaceuticals: Differences and Regulatory Approach” in New Progress and Challenges in Pharmaceutical Sciences, p.62-73, Hincal, A.A., Celebi, N., Yüksel, N. (Ed). 2010.
  11. ÇALIŞ, S. ‘‘Nanoaygıtlar’’ in Farmasötik Nanotaşıyıcılar ve Uygulamaları, Ayla Gürsoy (Ed.). 2013.
  12. ÇALIŞ, S. ‘‘Dendrimerler’’ in Farmasötik Nanotaşıyıcılar ve Uygulamaları, Ayla Gürsoy (Ed.). 2013.

III. Revıew artıcles

Published in National Journals

  1. YENİCE, İ., ÇALIŞ, S. “Ortopedik İmplantlara Yasal Yönden Yaklaşımlar”, TÜFTAD Der., Special Issue, 13 (4) 14-19, 2006  
  2. YENİCE, İ., ÇALIŞ, S., “Bioavailability File: Teicoplanin”  FABAD J. Pharm. Sci.,  26 (3),  143-155,  2001.  (in Turkish)
  3. TUNÇAY, M., ÇALIŞ, S., “ Biodegradable Synthetic and Natural Polymers Used in Drug Delivery Systems", FABAD  J. Pharm. Sci.,  24 (2) 109-123,  1999.  (in Turkish)
  4. BOZDAĞ, S., ÇALIŞ, S., ŞUMNU, M., "Bioavailability File: Omeprazole",  FABAD J. Pharm. Sci., 23,  111-118,  1998.  (in Turkish)
  5. BARUT, D., ÇALIŞ, S., TOKGÖZOĞLU M., “Use of Biopolymers in Treatment of Bone Infections” Hacettepe Medical Bulletin, Vol :29 (No: 4)  43-53, 1998.  (in Turkish)
  6. ÇALIŞ, S., ÜNLÜ, N.,  HINCAL,A.A., "Disinfection Action of Hypochlorite Solutions", Posyon, Vol: 5, (No: 1),  29-31,  1996.  (in Turkish)
  7. ÇALIŞ, S., "Protein Adsorption to The Solid Surfaces and Evaluation of Peptid/Polymer Interaction", Sendrom Medical Journal, Vol: 8, (No: 4),  102-109,  1996.  (in Turkish)
  8. HINCAL, A.A.,ÇALIŞ, S., "International Conference on Harmonization …” Aylık Rapor, (No:90-91) p.4-5, March, 1996.
  9. BOZDAĞ, S., ÇALIŞ, S., ŞUMNU, M., "Bioavailability: Diltiazem Hydrochloride", Hacettepe University Journal of The Faculty of Pharmacy,15 (1), 33-44, 1995. (in Turkish)
  10. HINCAL, A.A., ÇALIŞ, S., ÜNLÜ, N ., "The Importance of Sodium Hypochlorite Solutions on The Relationship of Health and Cleaning", Sağlık Magazin, No:4 58-59, 1995. (in Turkish)
  11. ÇALIŞ, S., ŞUMNU, M., HINCAL, A.A., "Topical Vaginal Dosage Forms, Their Formulations Applications and Controls”, FABAD  J. Pharm. Sci.,  19,  85-95, 1994.  (in Turkish)
  12. ÇALIŞ, S., ŞUMNU, M., HINCAL, A.A., "Bioavailability File: Propoxyphene", FABAD J. Pharm. Sci., 16  (3), 175-184, 1991.  (in Turkish)
  13. SAYIN, B., ÇALIŞ, S., “Bone Grafts” TÜFTAD J., Special Issue, 13 (4) 3-7, October – December 2006. (in Turkish)

Scientific Translations (Published in National Journals) (Published in Turkish Journals)

  1. ÇALIŞ, S., "Rekombinant DNA Teknolojisi  ve Eczacılığın Geleceği", FABADFarm.  Bil. Der., 7 (4), 219-223 (1982).
  2. ÇALIŞ, S., "Kloramfenikol İçeren Göz Damlaları ve Aplastik Anemi Üçüncü Dünya Ülkeleri İçin Bir Sorun Mu?", FABAD, Farm. Bil. Der. 9 (3), 195- 196 (1984).
  3. ÇALIŞ, S., "Kafein Bronkodilatör Olarak Değer Taşıyabilir",FABAD Farm. Bil. Der. 10 (1) 73 (1985).
  4. ÇALIŞ, S., "Transdermal Estradiol FDA Tarafından Onaylandı", FABAD Farm. Bil. Der. 12 (3), 236 (1987).
  5. ÜSTEL, İ., SUNAL, R., DALKARA, S., ÇALIŞ, S., UÇAR, G., "Eczacılık Eğitiminde Temel İlkeler,  Avrupa'da Eczacılık, Avrupa Ülkelerindeki Eczacılık Eğitimi ve Uygulaması", Hacettepe Üniversitesi Eczacılık Fakültesi  Dekanlığı Yayını: 1987- 1.
  6. ÇALIŞ, S., "Farmasötik Bilimlerin  Geleceği", TÜFTAD Haberler, 4 (4), 13, 1997.

IV. Oral presentations and posters

Presented in International Meetings

  1. ÇALIŞ, S., ŞUMNU, M., KIŞLALIOĞLU, S., HINCAL, A.A., "Degradation Kinetics of Propranolol Hydrochloride", 2nd International Pharmaceutical Technology Symposium, s. 18-19, October 3-4, 1984, Ankara,Turkey.
  2. ÇALIŞ, S., ŞUMNU, M., HINCAL, A.A., "In Vitro Adsorption of Propranolol  Hydrochloride by  Various Antacids",  5th  Pharmaceutical Technology Conference, Proceed.,  Vol II,  s. 132- 143, April 8-10, 1986, Harrogate, England.
  3. ÇAPAN, Y., ŞENEL, S., ÇALIŞ, S., HINCAL, A.A., "Formulation and Biopharmaceutical Evaluation of Sustained Release Tablets of Aspirin", 3rd International Pharmaceutical Technology Conference, September 9-11, 1986, Ankara, Turkey.
  4. ÇALIŞ, S., ŞUMNU, M., YULUĞ, N., HINCAL, A.A., "A Non-Antibiotic Antimicrobial Mixture Alkyl N-Betaine: Alkyl N-N Dimethylamine Oxide (C31G): Its Antimicrobial Evaluation and In Vitro Studies on Vaginal Suppository Formulations", 1st InternationalConference on Antimicrobial Activity of Non - Antibiotics, s. 33, May 27-29, 1990, Copenhagen, Denmark.
  5. ÇalIŞ, S., Şumnu, M., HIncal, A.A.,"Effect of Suppository Bases on the Release Properties of A Potent Antimicrobial Agent (C31G) and In Vitro Evaluation of Suppository Formulations", 50th International Congress of F.I.P., s. 170, September 3-7, 1990, İstanbul, Turkey.
  6. Ünlü, N., ÇalIŞ, S., Şumnu, M., HIncal, A.A., "The Surface Activity of a New Potent Antimicrobial Mixture (C31G) of Alkyl Betaines and Alkyl Amine Oxides", 50th International Congress of F.I.P., s. 182, September 3-7, 1990, İstanbul, Turkey.
  7. Ünlü, N., ÇalIŞ, S., İrkeç, M., Aksoy, F., Orhan, M., Şumnu, M., HIncal, A. A.,"Evaluation of the Irritation of a New Potent Antimicrobial Surfactant- C31G: An Irrigation Study on Rabbit Eyes", 18th International Symposium on Controlled Release of  BioactiveMaterials, Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 18 (1991), p. 511-512, July 8-11, 1991, Amsterdam, The Netherlands.
  8. ÇalIŞ, S., ÇalIŞ, Ü., Şumnu, M., HIncal, A.A., "Colorimetric Determination of A Novel Antimicrobial Surfactant Mixture (C31G)", 2nd Pharmaceutical Symposium with International Participation, s. 25, June 11-14, 1991, Ankara,Turkey.
  9. ÇalIŞ, S., Jeyanthi, R., Mehta,R.C., DeLuca, P.P., "High Adsorption Capacity of sCT  to  PGL Microspheres", AAPS Seventh Annual Meeting, Pharm. Res. (Suppl) 9 (10), p.251, 1992,  November 15-19, 1992, San Antonio, Texas-U.S.A.
  10. Jeyanthi, R., ÇalIŞ,S., Mehta, R.C., DeLuca, P.P., "Influence of  Processing Parameters on the Porosity of Poly (Glycolide-Co-Lactide) Microspheres", AAPS Seventh Annual Meeting, Pharm  Res. (Suppl) 9 (10), p. 252, 1992, November 15-19, 1992, San Antonio, Texas-U.S.A.
  11. ÇalIŞ, S., Jeyanthi,R., Mehta,R.C., DeLuca, P.P., "Effect of Matrix  Characteristics on the In Vitro Release of Calcitonin from PLGA  Microspheres", AAPS Eighth AnnualMeeting, November 15-19, 1992, Orlando, Florida-U.S.A. Pharm. Res. (Suppl) 10 (10), p. 277, 1993.
  12. ÇALIŞ, S., JEYANTHİ, R., MEHTA, R.C., DELUCA, P.P., "Development of a Controlled Peptide Delivery System : Release Behavior of sCT from PLGA Microspheres of Different Matrix Characteristics",Ninth International Symposium on  Microencapsulation, s. 12, September 13-15, 1993, Ankara,Turkey.
  13. ÇALIŞ, S., "Disinfection: Importance and Applications in Human Health", İstanbul Medical Faculty Post-Graduate Symposium and Educational Course, September 27-30, 1995, İstanbul,Turkey. (Invited Lecture) (in Turkish) 
  14. HINCAL, A.A., ÇALIŞ, S., ŞENEL, S., APİKOĞLU, Ş., "Developing Teaching Objectives in Pharmacetical Technology", European Association of Faculties of Pharmacy Meeting in Edinburgh, September 14, 1996.
  15. ÇALIŞ, S., BOZDAĞ, S., ŞUMNU, M., HINCAL, A.A., "In Vitro Adsorption of Diltiazem Hydrochloride Onto Some Antacids"Proceed. 8th Inter. Pharm. Technol. Symp. (IPTS-96), s. 161-162, September, 9-11, 1996, Ankara, Turkey.
  16. HINCAL, A.A., ÇALIŞ, S., "Recent Advances in Controlled Release Systems", Drug Industry and Manufacturers’ Association-Industrial Courses Institute, April 2-4, 1997, İstanbul, Turkey.  (Oral)
  17. BOZDAĞ, S., ÇALIŞ, S., ŞUMNU, M., “Formulation and In Vitro Evaluation of Enteric Coated Omeprazole Tablets”, 2nd Central European Symposium on PharmaceuticalTechnology, Abstract:  Farmaceutski Vestnik (special issue) vol: 48, 336-337 September 25-26, 1997, Portoroz, Slovenia.
  18. HINCAL, A.A., ÇALIŞ, S., ÖNER, F., KAŞ, H.S., “Special Interest Group’s Study on Present Status and Future Needs in Pharmaceutical Biotechnology: Questionnaire Evaluation”,57th International Congress of FIP, 1997 Vancouver, Canada.
  19. HINCAL, A.A., ŞENEL, S., ÇALIŞ, S., Evaluation of the Responses to the EAFP Questionnaire on "Developing Teaching Objectives in Pharmaceutical Technology” Educating for the Future" September 26-28, 1997, London, UK.
  20. TUNÇAY, M., ÇALIŞ, S., KAŞ, H.S., HINCAL, A.A., “Preparation and In Vitro Evaluation of Diclofenac Sodium Loaded Biodegradable Microspheres”, The 4th International Symposium on Biomedical Science and Technology, s. 55-56, September 15-17, 1997, İstanbul, Turkey.
  21. ÇALIŞ, S., BOZDAĞ, S., KAŞ, S., HINCAL, A.A., “Formulation and Characterization of Albumin Microspheres Containing Naproxen Sodium”, 5th European Symposium onControlled Drug Delivery, Proceeding: J. Controlled Rel. 64, 269-271, 2000, April 1-3, 1998, The Netherlands.
  22. TUNÇAY, M., ÇALIŞ, S., KAŞ, S., ERCAN, M.T., ERTÜRK, H., HINCAL, A.A., “Diclofenac Sodium Incorporated Biodegradable Microspheres II: Antiinfammatory Activity In The Knee Joint of Rabbits, Conference on Challenges for Drug Delivery and Pharmaceutical Technology, pp 188, June 9-11,1998, Tokyo, Japan.
  23. TUNÇAY, M., ÇALIŞ, S., KAŞ, H.S., ERCAN, M.T., SARGON, M.F., HINCAL, A.A., “Diclofenac Sodium Incorporated PLGA Microspheres: Formulation Considerations and In Vitro Study”, 9th International Pharmaceutical Technology Symposium, s. 71-72, September 7-9, 1998, Ankara, Turkey.
  24. ÇALIŞ, S., HINCAL, A.A., “Poly Lactide- Co- Glycolide Polymers: Properties, Preparation and Applications in Pharmaceutical Formulations, Advanced Biopolymer Systems”, First Japanese Turkish Workshop, September 16-19, 1998, Gebze, Turkey. (Invited Lecture)
  25. BOZDAĞ, S., ÇALIŞ, S., KAŞ, H.S., SARGON, M.F., HINCAL, A.A., “In Vitro Evaluation of Naproxen Sodium Loaded Poly (D,L- Lactide- Co- Glycolide) Microspheres”, Bioencapsulation VII, November 20-23,1998, Easton, Maryland, USA.
  26. BOZDAĞ, S., ÇALIŞ, S., KAŞ, H.S., ÇAPAN, Y., ERCAN, M.T., ERTÜRK, H., HINCAL, A.A., “Intraarticular Administration of Biodegradable Microspheres Containing Naproxen Sodium”, AAPS Annual Meeting and Exposition, Abstract: Pharm Sci., p.198 November 15-19, 1998, San Francisco, USA.
  27. ÇALIŞ, S., BOZDAĞ, S., TUNÇAY, M., KAŞ, H.S., HINCAL, A.A., "Gamma Irradiation Effects on Biodegradable Diclofenac Sodium Microspheres", ECBP and EUFEPS Joint Symposium, Abstract: European J. Pharm. Sci., Vol 8/2, s. 20, April 25-30, 1999, Jarusalem, Israel.
  28. ÇALIŞ, S., ÖNER, F., KAŞ, H.S., HINCAL, A.A., "Present Status and Future Needs in Pharmaceutical Biotechnology", The Second International Clinical Pharmacy Conference: Oppurtunities and Challenges, April 21-22, 1999, Amman, Jordan.
  29. ÇALIŞ, S., BOZDAĞ, S., KAŞ, H.S., HINCAL, A.A., "Influence of Irradiation Sterilization on Naproxen Sodium Containing PLGA Microspheres", s. 31, 12th International Symposium on Microencapsulation, September 6-8, 1999, London, UK.
  30. DOĞRU, T., ÇALIŞ, S., ÖNER, F., "Oral Multiple w/o/w Emulsion Formulation and In Vitro Evaluation of a Peptide Salmon Calcitonin", s. 32, 12th International Symposium on Microencapsulation, September 6-8, 1999, London, UK.
  31. YENİCE, İ., ÇALIŞ, S., ÇAPAN, Y., HINCAL, A.A., “The Quality Control Studies on Conventional and Controlled Release Carbamazepin Tablets”, 6th Science and Technology Symposium with International Participation, (BİOMED-6), s. 39, October 6-8, 1999, Bornova, İzmir, Turkey.
  32. DOĞRU, T., ÇALIŞ, S., ÖNER, F., SALMANOĞLU, B., ALPAR, R., HINCAL, A.A., "Evaluation of Oral Delivery of Salmon Calcitonin Using W/O/W Multiple Emulsion Formulation" 6th European Symposium on Controlled Drug Delivery, Ed: A.P. Sam. Proceeding: J.Control.Rel. 72 (1-3), 293-295, 2001, April 12-14, 2000, Netherlands.
  33. ARICA, B., ÇALIŞ, S., VURAL, İ., KAŞ, S., KUMBARADZİ F., HINCAL, A.A., "5-FU Loaded PLGA Microspheres Blended with Chitosan Gel forLocal Application in Breast Cancer: Formulation and In Vitro Release Profiles", 6th European Congress of Pharmaceutical Sciences, Abstract:  Eur J.Pharm. Sci., Vol. 11 Suppl 1, p.S36 September 16-19, 2000, Budapest, Hungary.
  34. VURAL, İ., ÇALIŞ, S., ARICA, B., KAŞ, S., KUMBARADZİ, F., HINCAL, A.A., "Formulation and In Vitro Characterization of Chitosan Treated 5-FU Liposomes for Local Application in Breast Cancer", 6th European Congress of Pharmaceutical Sciences, Abstract:  Eur J.Pharm. Sci., Vol. 11 Suppl 1, p.S56 September 16-19, 2000, Budapest, Hungary.
  35. YENİCE, İ., ÇALIŞ, S., KAŞ, S., ÖZALP, M., EKİZOĞLU, M., HINCAL, A.A., "Teicoplanin A Glycopeptide Antibiotic: Stability and Microbiological Evaluation" 6th European Congress of Pharmaceutical Sciences, Abstract:  Eur J.Pharm. Sci., Vol. 11 Suppl 1, p. S57 September 16-19, 2000, Budapest, Hungary.
  36. BOZDAĞ, S., ÇALIŞ, S., ŞUMNU, M., "Validation of an HPLC Method for the Determination of Omeprazole", 6th European Congress of Pharmaceutical Sciences, Abstract:  Eur J.Pharm. Sci., Vol. 11 Suppl 1, p. S61 September 16-19, 2000, Budapest, Hungary.
  37. HINCAL, A. A., ÇALIŞ, S., HINCAL, F., "Reasons, Necessities and Developments for New Disciplines in Research and Education in Pharmaceutical Sciences", New Orientations of Teaching, May 4-6, 2001, Brussels, Belgium.  (Oral presentation)
  38. ÇALIŞ, S., ARICA, B., KAŞ, H.S., HINCAL, A.A., “An Antiinflammatory Drug (Ibuprofen) Incorporated in Biodegradable Alginate Beads” World Congress of Pharmacy and Pharmaceutical Sciences, 61st International Congress of FIP, pp 81., September 1-6, 2001, Singapore.
  39. ARICA, B., ÇALIŞ, S., KAŞ, H.S., SARGON, M.F., HINCAL, A.A., “5-FU Encapsulated Alginate Beads for the Treatment of Breast Cancer” 13th International Symposium on Microencapsulation, pp-p 119, September 5-7, 2001, Angers, France.
  40. YENİCE, İ., ÇALIŞ, S., KAŞ, S., ÖZALP, M., EKİZOĞLU, M., HINCAL, A.A., “Biodegradable Implantable Teicoplanin Beads for the Treatment of Bone Infections” 13th International Symposium on Microencapsulation, pp-p120, September 5-7, 2001, Angers, France.
  41. SIMONOSKA, M., KUMBARADZI-FREDRO, E., GLAVAS-DODOV, M., ÇALIŞ, S., GORACINOVA, K., MLADENOVSKA, K., HINCAL, A.A., “Release Profile of 5-FU Loaded Liposomes Stabilized By Liophilization” Third Yugoslav Congress of Pharmacy With International Participation, Abstract: Arhiv Za Farmaciju 52 (4), p.618, 2002., New Horizons in Pharmacy, October 29 - November 2, 2002, Belgrade,  Yugoslavia.
  42. JOLEVSKA, S.T., KUMBARADZI, E.F., STOJANOVSKA, I., DIMITROVSKA, A., DODOV, M.G., ÇALIŞ, S., HINCAL, A.A., “HPLC Determination of 5-Fluorouracil in Liposome Dispersion”, p.136-137, 11th International Pharmacetical Technology Symposium, September 9-11, 2002, İstanbul, Turkey.
  43. DODOV, M.G., KUMBARADZI, E.F., ÇALIŞ, S., ARICA, B., GORACINOVA, K., MLADENOVSKA, K., HINCAL, AA.,”The Effect of Cholesterol on the Encapsulation Efficiency and Drug Release From 5-FU Loaded Liposomes” p. 134-135, 11th International Pharmacetical Technology Symposium, September 9-11, 2002, İstanbul, Turkey.
  44. DODOV, M.G., KUMBARADZI, E.F., ÇALIŞ, S., ARICA, B., GORACINOVA, K., MLADENOVSKA, K., HINCAL, A.A., “ The Effect of Hydration Condition on Physical and Biopharmaceutical Characteristics of 5-FU Loaded Liposomes” APGI, 10th International Conference on Pharmaceutical Tecnology,  4th Meeting on Pharmaceutics, Biopharmaceutics, Pharmaceutical Technology, April 8-11, 2002, Florence.
  45. ATİLLA, B., TOKGÖZOĞLU, A.M., ÇALIŞ, S., YENİCE, İ., ÇAĞLAR, Ö., ÖZALP, M., BİLGİLİ, H., ALPASLAN, A.M.,"Controlled Delivery of Teicoplanin from an Intraarticular Biodegradable Microparticulate System; In vitro / In vivo Evaluation" American Academy of Orthopaedic Surgeons, 3, 458-459, 2002, Proceedings Annual Meeting, February 13-17, 2002, TEXAS, USA.
  46. ÇIRPANLI, Y., ÜNLÜ, N., ÇALIŞ, S., HINCAL, A.A., “All-Trans-Retinoic Acid Loaded Ocular Microspheres: Preparation and In-Vitro Characterization” Proceedings 30th Annual Meeting&Exposition of the Controlled Release Society, s. 234, July 19-23, 2003, Glasgow, Scotland, UK.
  47. ÇALIŞ, S., ARICA, B., ATİLLA, P., DURLU, T., ÇAKAR, N., HINCAL, A.A., “Effect of Ibuprofen Incorporated Biodegradable Alginate Beads on Gastric and Duodenal Mucosa (A Comparative Histological Study)” Proceedings 30th Annual Meeting&Exposition of the Controlled Release Society, July 19-23, 2003, Glasgow, Scotland, UK.
  48. SAYIN, B.,  ÇALIŞ, S., ATİLLA, B., SARGON, M., HINCAL, A.A., “Evaluation of In Vitro Antibiotic Release from Vancomycin Loaded Poly (Lactide-co-Glycolide) PLGA (75:25) Microspheres-Human Bone Grafts Blend” Proceedings 30th Annual Meeting&Exposition of the Controlled Release Society, July 19-23, 2003, Glasgow, Scotland, UK.
  49. HINCAL, A.A., MEMİŞOĞLU-BİLENSOY, E., ÇALIŞ, S., HINCAL, F., “Critical Parameters Concerning the Design of a Pharmaceutical Dosage Form for Potential Use Against Bioterrrorism and Chemical Weapons: An Overview on Current Concepts and Future Prospects” CBMTS-Industry III The National Medicinal Stockpilles Workshop, September 6-7, 2003, Dubrovnik.
  50. ÜNLÜ, N., ÇIRPANLI, Y., ÇALIŞ, S., SARGON, M., HINCAL, A.A., “Preparation and In-Vitro Characterization of PLGA (50:50) Microparticles Containing All-Trans-Retinoic Acid” 1st EUFEPS Conference on Optimising Drug Delivery and Formulation: New Challenges in Drug Delivery, 29 September-1 October, 2003, Paris, France.
  51. ÇALIŞ, S., SAYIN, B., ATİLLA, B., SARGON, M., HINCAL, A.A., “Evaluation of Vancomycin Impregnated Bone Grafts and Vancomycin Loaded Poly (Lactide-co-Glycolide) (PLGA (75:25)) Microspheres-Bone Grafts Blend for the Treatment of Surgical Bone Infections” 1st EUFEPS Conference on Optimising Drug Delivery and Formulation: New Challenges in Drug Delivery, 29 September-1 October, 2003, Paris, France.
  52. SAYIN, B., ÇALIŞ, S., ÖZALP, M., EKİZOĞLU, M., HINCAL, A.A., “Preparation Characterization and Stability Evaluation of Vancomycin Incorporated Poly (Lactide-co-Glycolide) (75:25) Microspheres for Implantation in Orthopaedic Applications” 10th Biomedical Science and Technology Symposium, October 10-12, 2003, METU Campus of Northern Cyprus.
  53. DODOV, M.G., KUMBARADZİ, E.F., GORACINOVA, K., MLADENOVSKA, K., SIMONOSKA, M., ÇALIŞ, S., HINCAL, A.A. “The Effect of Liophilisation on the Stability of Liposomes Containing 5-FU”, Farm Vestn (special issue), 54, 427-428, 2003, Proceedings 5th Central European Symposium on Pharmaceutical Technology and Biotechnology, 2003, Slovenia.
  54. DODOV, M.G., KUMBARADZİ, E.F., GORACINOVA, K., SIMONOSKA, M., ÇALIŞ, S., HINCAL, A.A. “The Release of 5-FU from Liposomes as a Function of the Formulation Variables” European Conference on Drug Delivery and Pharmaceutical Technology, May 10-12, 2004, Sevilla, Spain.
  55. ÇIRPANLI, Y., ÜNLÜ, N., ÇALIŞ, S., HINCAL, A.A., “All-Trans-Retinoic Acid Microspheres:  Preparation and In Vitro Characterization”, Eur. J. Pharm. Sci. (Suppl), 23(1), S53, PO-57, 2004, EUFEPS 2004 New Safe Medicines Towards Mechanistic Prediction, October 17-20, 2004, Brussels, Belgium.
  56. ŞAMDANCIOĞLU, S., ÇALIŞ, S., ŞUMNU, M., HINCAL, A.A., “Formulation and In Vitro Evaluation of Bisphosphonate Loaded Chitosan Microspheres for Implantation in Osteolysis” Eur. J. Pharm. Sci. (Suppl), 23(1), S52, PO-55, 2004, EUFEPS 2004 New Safe Medicines Towards Mechanistic Prediction, October 17-20, 2004, Brussels, Belgium.
  57. SAYIN B., ATİLLA B., ÇALIŞ, S., MARANGOZ, S., HINCAL, A.A, “In vivo Evaluation of Intraarticular Vancomycin Delivery Following Implantation of Antibiotic Loaded Allografts and Biopolymeric Microparticules into Bone Defects” , XIX. National Orthopedia and Travmatology Congress, May 14-19, 2005, Antalya., Acta Orthopaedica et Traumatologica Turcica (Suppl. II), 39, S-20, s.33, 2005.
  58. AKGÜN, R.C., ATİLLA, B., SAYIN, B., ÇALIŞ, S., TOKGÖZOĞLU, A.M., ALPASLAN, A.M., “İki Aşamalı Enfekte Total Protez Revizyonunda İlk Aşamada İmplante Edilen Çimento Dolgu Protezlerden (Spacer) Vankomisin Salımı” XIX. National Orthopedia and Travmatology Congress, May 14-19, 2005, Antalya, Acta Orthopaedica et Traumatologica Turcica (Suppl. II), 39, S-32, s.39, 2005. (In Turkish)
  59. LALECİ, F., ÇALIŞ, S., HINCAL, A.A., “Preparation and In Vitro Evaluation of Tolmetin Sodium Loaded Oral Eudragit Microspheres” Eur. J. Pharm. Sci. (Suppl. 1), 25, P62, s.146, 2005, 6th European Symposium on Pharmaceutical Technology and Biotechnology, May 25-27, Siofok, Hungary.
  60. ŞAMDANCIOGLU, S., ÇALIŞ, S., ŞUMNU, M., HINCAL, A.A., “Alendronate Sodium Incorporated Alginate Beads for Implantation in Orthopaedics” PharmSciFair, June 12-17, 2005, Nice, France.
  61. SAYIN B., ATİLLA B., ÇALIŞ, S., MARANGOZ, S., HINCAL, A.A.,  “In Vivo Evaluation of Intraarticular Vancomycin Delivery Following Implantation of Antibiotic Loaded Allografts and Biopolymeric Microparticules into Bone Defects” (oral presentation) XXIII SICOT/SIROT Triennial World Congress, September 2-9, 2005 İstanbul, Turkey.
  62. ARICA, B., ÇALIŞ, S., GÜLER, N., KUMBARADZİ, E.F., HINCAL, A.A., “The Topical Application of 5-Fluorouracil (5-FU) Loaded Beads Having to Breast Cancer Patients Chestwall Recurrences” 15th International Symposium on Microencapsulation, September 18-21, 2005, Parma-Italy.
  63. ŞAMDANCIOĞLU, S., ÇALIŞ, S., ŞUMNU, M., HINCAL, A.A., “Biphosphonate Loaded PLGA (50:50) Microspheres for Implantation in Osteolysis” 15th International Symposium on Microencapsulation, September 18-21, 2005, Parma-Italy.
  64. LALECİ, F., ÇALIŞ, S., HINCAL, A.A., “Tolmetin Sodium Loaded Eudragit S 100 Microspheres: Preparation, In Vitro Evaluation and Stability Studies” 15th International Symposium on Microencapsulation, September 18-21, 2005, Parma-Italy.
  65. ÇIRPANLI, Y., AKSUNGUR, P., ÜNLÜ, N., ÇALIŞ, S., HINCAL, A.A., “Stability Assessment of All-Trans-Retinoic Acid Microspheres” 15th International Symposium on Microencapsulation, September 18-21, 2005, Parma-Italy.
  66. SARISÖZEN, C., ÇALIŞ, S., ARICA, B., HINCAL, A.A. “Development of Prednisolone Acetate Incorporated Microspheres by Spray-Drying Technique” APGI and APV- 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, March 27-30, 2006, Geneva.
  67. BİLENSOY, E, ÇIRPANLI, Y., SALİH, B., ŞEN, M., ÇALIŞ, S., “Thermosensitive Mucoadhesive Gel Formulation Loaded With 5-FU: Cyclodextrin Complex For HPV-Induced Cervical Cancer” 13th International Cyclodextrin Symposium, May 14-17, 2006, Torino, Italy.
  68. ÇIRPANLI, Y., BİLENSOY, E, ÇALIŞ, S., ŞEN, M., HINCAL, A.A. “Camptothecin Inclusion Complexes with Natural and Modified β-Cyclodextrins” 33rd Annual Meeting & Exposition of the Controlled Release Society, July 22-26, 2006, Vienna, Austria.
  69. GLAVAS-DODOV, M., ÇALIŞ, S., SİMONOSKA, M. S., GORACİNOVA, K., “Formulation and Evaluation of 5-FU Loaded Chitosan/Alginate Microparticles Prepared by Spray-Drying“, s. 61, 13th International Pharmaceutical Technology Symposium, September 10-13, 2006, Turkey.
  70. SARISÖZEN, C., ARICA, B., ÇALIŞ, S., HINCAL, A.A. “Development of Biodegradable Polymeric Cardiovascular Stents and In Vitro Evaluation” 2006 AAPS Annual Meeting and Exposition, October 29 - November 2, 2006, San Antonio, Texas, USA.
  71. SARISÖZEN, C., ARICA, B., ÇALIŞ, S., HINCAL, A.A. “Prednisolone Acetate-Eluting Novel Biodegradable Vascular Stents For Implantation”, GPEN 2006, October 25-27, 2006, University of Kansas, Lawrence, USA.
  72. ÇALIŞ, S., OZLU, E., KILIC, M.A. “A New Protein-based Drug Carrier: The Ferritin-Doxorubicin Complex” EUFEPS Workshop on Optimizing Biotech Medicines, January 11-12, 2007, Munich, Germany.
  73. SARISÖZEN, C., ARICA, B., ÇALIŞ, S., HINCAL, A.A. “In Vitro Evaluation of Polymer Coated Prednisolone Acetate Eluting Cardiovascular Stents” Pharmaceutical Sciences World Congress, April 22-25, 2007, Amsterdam, The Netherlands.
  74. ÇIRPANLI, Y., BİLENSOY, E, ÇALIŞ, S., ŞEN, M., HINCAL, A.A. “Development of Camptothecin Loaded Nanoparticles from Amphiphilic β-Cyclodextrin Derivatives” Pharmaceutical Sciences World Congress, April 22-25, 2007, Amsterdam, The Netherlands.
  75. SARISÖZEN, C., ARICA, B., ÇALIŞ, S., HINCAL, A.A. “Physicochemical Characterization of Biodegradable Cardiovascular Stents” International Symposium on Drug Research and Development from Chemistry to Medicine, May 17-20, 2007, Antalya, Turkey.
  76. ÇIRPANLI, Y., BİLENSOY, E, ÇALIŞ, S., HINCAL, A.A. “Stabilization of Camptothecin in PLGA Nanoparticles” The 2nd BBBB Conference on Pharmaceutical Sciences, September 13-15, 2007, Tallinn-Tartu, Estonia. (oral presentation)
  77. ARICA, B., ÇALIŞ, S., GORACINOVA, K., HINCAL, A.A. “In Vitro Evaluation of 5-Fluorouracil-Loaded Enteric Coated PLGA Microparticles Prepared by Spray-Drying Technique” Fourth Congress of Pharmacy of Macedonia with International Participation, s. 50, September 26-30, 2007, Ohrid, Macedonia.
  78. ÇALIŞ, S. “Implantable Biodegradable Microparticles for Orthopoedical Applications” Fourth Congress of Pharmacy of Macedonia with International Participation, s. 37, September 26-30, 2007, Ohrid, Macedonia. (Invited lecturer)
  79. GLAVAS DODOV, M., HINCAL, A., ÇALIŞ, S., SİMONOSKA CRCAREVSKA, M., GESKOVSKİ, N., GORACİNOVA, K. Spray-Dried Chitosan-Ca-Alginate Microparticles for Colon Delivery, Fourth Congress of Pharmacy of Macedonia with International Participation, s. 45, September 26-30, 2007, Ohrid, Macedonia.
  80. SARISÖZEN, C. , ÇALIS, S., ARICA, B., HINCAL, A. A. Prednisolone Acetate Incorporated Chitosan Microspheres for Preventing Restenosis, 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, April 7-10, 2008, Barcelona, Spain.
  81. CIRPANLI, Y., BILENSOY, E., CALIS, S. Formulation and In Vitro Evaluation of Camptothecin Loaded Poly-e-Caprolactone Nanoparticles, 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, April 7-10, 2008, Barcelona, Spain.
  82. GLAVAS DODOV, M., HINCAL, A. A., CALIS, S., SIMONOSKA CRCAREVSKA, M., MLADENOVSKA, K., GESKOVSKI, N., GORACINOVA, K. Chitosan-Ca-Alginate Microparticles Loaded With Hpmcp Hp55 Coated 5-Fu: Physical Characterization, 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, April 7-10, 2008, Barcelona, Spain.
  83. GLAVAS DODOV, M., HINCAL, A. A., CALIS, S., SIMONOSKA CRCAREVSKA, M., MLADENOVSKA, K., GESKOVSKI, N., GORACINOVA, K. Spray-Dried 5-FU Loaded Chitosan-Ca-Alginate Microparticles for Local Colon Delivery, Abstractbook of 1st International Conference on Drug Design and Discovery, 2008, Dubai.
  84.  ÇAKMAK, A., SARIBA޸ Z., ÇIRPANLI, Y., ÇALIS¸ S., HASÇELİK, G., YORGANCI, K., KAYNAROĞLU, V. Antibacterial Effects of Triclosan Coated Polypropylene Grafts on Graft Infection Model in Rats, 21st European Congress Surgical Infection Society–Europe, May 1–3, 2008, Antalya, Turkey.
  85.  ARICA, B., CALIS, S., GORACINOVA, K., HINCAL, A.A. Preparation and Evaluation of Lectin-Conjugated 5-Fluorouracil (5-FU) Loaded PLGA Microparticles for Colon Delivery, 35th Annual Meeting & Exposition of the Controlled Release Society, July 12-16, 2008, New York City, USA.
  86. ÇIRPANLI, Y., BİLENSOY, E., PASSIRANI, C., ÇALIŞ, S., BENOIT, J.P. Evaluation of Camptothecin Loaded Nanoparticles for Malignant Gliomas, Globalization of Pharmaceutical Education Network-GPEN 2008, September 9-12, 2008, Leuven, Belgium.
  87. ÇIRPANLI, Y., BİLENSOY, E., ÇAKMAK, A., ÇALIŞ, S. Formulation and In Vitro - In Vivo Evaluation of Triclosan Coated Grafts, 7th Central European Symposium on Pharmaceutical Technology and Biodelivery Systems, September 18-20, 2008, Ljubljana, Slovenia.
  88.  GLAVAS DODOV, M., HINCAL, A. A., CALIS, S., STEFFANSEN, B., SIMONOSKA CRCAREVSKA, M., GORACINOVA, K. WFA Functionalized Chitosan-Ca-Alginate Microparticles Loaded with 5-FU for Local Treatment for Colon Cancer, 7th Central European Symposium on Pharmaceutical Technology and Biodelivery Systems, September 18-20, 2008, Ljubljana, Slovenia.
  89.  ÇIRPANLI, Y., ROBINEAU, C., ÇAPAN, Y., ÇALIŞ, S. Etodolac Loaded Poly(Lactide-co-Glycolide) Nanoparticles: Formulation and In Vitro Characterization, International Symposium on Drug Research and Development 2009, From Chemistry to Medicine & Educational Fair on "GLP and Laboratory Safety: New Approaches", Mayıs 4-7, 2009  Ankara, Turkey.
  90. ÇABAN, S., CHOPLIN, J., ÇALIŞ, S., ÇAPAN, Y. Naproxen Sodium Loaded Chitosan Nanoparticles: Formulation and In Vitro Characterization, International Symposium on Drug Research and Development 2009, From Chemistry to Medicine & Educational Fair on "GLP and Laboratory Safety: New Approaches", May 4-7, 2009,  Ankara, Turkey.
  91.  GORACINOVA, K., STEFFANSEN, B., GLAVAS, M., ÇALIŞ, S. Importance of Physico-Chemical Characteristics of Smart Carriers for Improved Therapeutic Efficacy, International Symposium on Drug Research and Development 2009, From Chemistry to Medicine & Educational Fair on "GLP and Laboratory Safety: New Approaches", May 4-7, 2009,  Ankara, Turkey (Oral Presentation).
  92. CHOPLIN, J., ROBINEAU, C., ÇIRPANLI, Y., ÇABAN, S., ÇALIŞ, S., ÇAPAN, Y. Non Steroidal Anti Inflammatory Drugs Loaded Poly(Lactide-co-Glycolide) and Chitosan Nanoparticles: Formulation and In Vitro Characterization, 2nd PharmSciFair 2009-Premier European Platform for Advancing Pharmaceutical Sciences, June 8-12, 2009, Nice, France.
  93. YAĞ, G., ARICA, B., ÇALIŞ, S. Formulation and In Vitro Characterization of Tolmetin Sodium Loaded  Eudragit® Microspheres, 2nd PharmSciFair 2009-Premier European Platform for Advancing Pharmaceutical Sciences, June 8-12, 2009, Nice, France.
  94. BİLENSOY, E., MOROY, P., ÇIRPANLI, Y., BİLENSOY, T., ÇALIŞ, S., MOLLAMAHMUTOĞLU, L. Placebo Controlled Clinical Trial of Thermosensitive Gel Loaded with 5-FU:Cyclodextrin Complex for Treatment of HPV-Induced Genital Lesions. The First European Cyclodextrin Conference, October 11-13, 2009, Denmark.
  95. ÇALIŞ, S. Medical Devices and Pharmaceuticals: Differences and Regulatory Approach, Eur. J. Pharm. Sci. Supp., 38(1), (2009), 12-13, 3rd BBBB International Conference on Pharmaceutical Sciences, October 26-28, 2009, Antalya, Turkey.
  96. YAĞ, G., ARICA, B., ÇALIŞ, S. Studies on the Improvement of Encapsulation Efficiency of a Hydrophilic Drug, Eur. J. Pharm. Sci. Supp., 38(1), (2009), 87-88, 3rd BBBB International Conference on Pharmaceutical Sciences, October 26-28, 2009, Antalya, Turkey.
  97. YERLİKAYA, F., LAUNAY, M., GEGU, C., LETURGEZ, T., BİLENSOY, E., ÇALIŞ, S., ÇAPAN, Y. Analytical Method Development and Validation of Tamoxifen Citrate Using Normal Phase High Performance Liquid Chromatography, Eur. J. Pharm. Sci. Supp.,38(1), (2009), 95-96, 3rd BBBB International Conference on Pharmaceutical Sciences, October 26-28, 2009, Antalya, Turkey.
  98. GLAVAS DODOV, M., CALIS, S., KUZMANOVSKA, S., CRCAREVSKA, M. S., PETROVSKA, V., N. GESKOVSKİ, GORACİNOVA, K. Muco/Bıoadhesive Properties and In Vivo Biodistribution of Chitosan-Ca-Alginate Microparticles Loaded With 5-FU, Eur. J. Pharm. Sci. Supp., 38(1), (2009), 183-184, 3rd BBBB International Conference on Pharmaceutical Sciences, October 26-28, 2009, Antalya, Turkey.
  99. LAUNAY, M., GEGU, C., LETURGEZ, T., CIRPANLI, Y., OZTURK, K., ERDOGAR, N., YERLİKAYA, F., BİLENSOY, E., CALIS, S., CAPAN, Y. Comparative Evaluation of In Vitro Parameters of Tamoxifen Citrate Loaded Chitosan, Poly(ε-Caprolactone) and Poly(Lactide-co-Glycolide) Nanoparticles. 7th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, March 8-11, 2010, Malta.
  100. ÇIRPANLI, Y., BİLENSOY, E., DOĞAN, A.L., ÇALIŞ, S. “Development of Polymeric and Cyclodextrin Nanoparticles for Camptothecin Delivery” 11th European Symposium on Controlled Drug Delivery Abstract Book, , p.273-276, April 7-9, 2010, Egmond aan Zee, The Netherlands.
  101. SIMONOSKA CRCAREVSKA, M., GLAVAS DODOV, M., CALIS, S., PETROVSKA, V., GESKOVSKI, N., GORACINOVA, K. “Physico-Chemical Characterization of Biodegradable Polymeric Nanoparticles Loaded With CPT-11” 4. Croatian Congress o Pharmacy, May 27-30, 2010, Opatija, Croatia.
  102. CRCAREVSKA, M.S., DODOV, M.G., CALIS, S., PETROVSKA, V., GESKOVSKI, N., GORACINOVA, K. “CPT-11 Loaded PLGA Nanoparticles: Formulation and Optimization” XXI Congress of Chemist and Technologist of Macedonia, September 23-26, 2010, Ohrid, Macedonia.
  103. CRCAREVSKA, M.S., DODOV, M.G., CALIS, S., PETROVSKA, V., GESKOVSKI, N., GORACINOVA, K. “Formulation and Optimization of biodegradable CPT-11 loaded nanocarriers for anticancer and/or combined anticancer and gene therapy”, 15th International Pharmaceutical Technology Symposium, September 13-15, 2010, Antalya.
  104. ÇIRPANLI, Y., ARİCA-YEGİN, B., GORACİNOVA, K., ÇALIŞ, S. “Amphiphilic Carriers for Targeted Anticancer Drug Delivery” AAPS Meetings & Education: 2010 PSWC Annual Meeting, November 14-18, 2010, New Orleans, USA.
  105. ÇIRPANLI, Y., BOZDAG-PEHLİVAN, S., EKİZOGLU, M., BODUR, E., OZALP, M., ÇALIŞ, S. “In Vitro Evaluation Of Vancomycin Microspheres In Serratiopeptıdase Loaded Thermosensitive Gel For The Treatment Of Bacterial Biofilm” 4th BBBB-Bled International Conference on Pharmaceutical Sciences, September 29 – October 2011, Bled, Slovenia.
  106. CRCAREVSKA, M.S., CALIS, S., GESKOVSKI, N., KUZMANOVSKA, S., DODOV, M.G., GORACINOVA, K. (2011) “Preparation and Biological Evaluation of irinotecan hydrochloride loaded biodegradable nanocarriers for tumour delivery by EPR effect, 3rd PharmSci Fair, Prague, Czech Republic.
  107. CRCAREVSKA, M.S., DODOV, M.G., CALIS, S., GESKOVSKI, N., GORACINOVA, K. (2011) “Strategies for Improvement of the EPR Effect of PLGA Amphipilic Nanoparticles” Macedonian Pharmaceutical Bulletin, 57, supp1, 306-307, 5th Congress of Pharmacy of Macedonia, September 21-25, 2011, Ohrid-Macedonia.
  108. CRCAREVSKA, M.S., GESKOVSKI, N., DODOV, M.G., CALIS, S., DIMCEVSKA, S., GORACINOVA, K., (2011) “Physico-chemical properties of PLGA amphipilic nanoparticles and solid tumor targeting, Macedonian Pharmaceutical Bulletin, 57, supp1, 214-215, 5th Congress of Pharmacy of Macedonia, September 21-25, 2011, Ohrid, Macedonia.
  109. GESKOVSKI, N., KUZMANOVSKA, S., CRCAREVSKA, M.S., CALIS, S., DODOV, M.G., KOCOVSKA, Z.M., GORACINOVA, K., (2011) 99mTc radiolabeling of Nanoparticles for Biodistribution and Efficacy Studies, Macedonian Pharmaceutical Bulletin, 57, supp1, 216-217, 5th Congress of Pharmacy of Macedonia, September 21-25, 2011, Ohrid, Macedonia.
  110. ÇALIŞ, S. “Medical Device/Drug Combination Products: A Perfect Mix for Biotherapeutics”, Macedonian Pharmaceutical Bulletin, 57, supp1, 226, 5th Congress of Pharmacy of Macedonia, September 21-25, 2011, Ohrid, Macedonia. (Invited Lecturer)
  111. ÖZTÜRK K., TULU M., ÇALIŞ, S., “Drug-Dendrimer Complex: Novel and Potential Systems for Oral Antiinflamatory Drug Delivery” 2011 AAPS Annual Meeting and Exposition, October 23-27, 2011, Washington, DC, USA.
  112. CALIS, S., ÖCAL, H., ARICA-YEGIN, B., GORACINOVA, K., “ 5-Fluorouracil loaded PLG/PLGA PEG-PPG-PEG polymeric nanoparticles: Formulation and in vitro characterization” 8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, March 19-22, 2012, İstanbul.
  113. CALIS, S., “Overview of Drug/Device Combinations and Use in Local Therapies” 16th International Pharmaceutical Technology Symposium, September 10-12, 2012, Antalya, Turkey. (Invited Lecturer)
  114. SARIGOL, E., BOZDAG PEHLIVAN S., CALIS, S., “Vancomycin HCl Loaded Poly(ε-Caprolactone) Microspheres: Preparation and in Vitro Characterization” 16th International Pharmaceutical Technology Symposium, September 10-12, 2012, Antalya, Turkey.
  115. OCAL, H., ARICA YEGIN, B., VURAL, I., GORACINOVA, K., CALIS, S., “5-FU Loaded PLA/PLGA PEG-PPG-PEG Polymeric Nanoparticles: Characterization and Cell Culture Studies” 9th Central European Symposium on Pharmaceutical Technology, September 20-22, 2012, Dubrovnik, Croatia.
  116. OZTURK, K., SARISOZEN, C., ERTURK, A.S., TULU, M., “Effect of Generation Number and Concentration on in vitro Characterization and Cytotoxicity of Dendrimers” 2012 AAPS Annual Meeting and Exposition, October 14-18, 2012, Chicago, IL, USA.
  117. CELEN, N. , OZTURK, K. , BILENSOY, E. , CALIS, S.,Enhanced Solubility of Cefixime, a Poorly Soluble Drug, with Using Hydroxypropyl β-Cyclodextrin, 3rd European Conference on Cyclodextrins, 2-4 October 2013, Antalya, TURKEY.
  118. CALIS, S., “Introduction and Overview of Drug/Device Combination Products” 17th International Pharmaceutical Technology Symposium, September 8-10, 2014, Antalya, Turkey. (Invited Lecturer)
  119. ÖZTÜRK, K, GÜRBÜZ, M.U., TÜLÜ, M.,ÇALıŞ S. ‘‘Development of Dendrimer-based Nanocarrier System for Cancer Therapy’’,  2014 AAPS Annual Meeting and Exposition, 2-6 November 2014, San Diego, ABD.
  120. Preparation and In Vitro Characterization of 5-Fluorouracil loaded biodegradable Nanoparticles, A. R. Mashal 1, K. Ozturk 2, B. Arica Yegin 2, S. Calis, 2014 AAPS Annual Meeting and Exposition, November 2-6, 2014, San Diego, USA.

Presented in National Meetings

  1. ÇalIŞ, S., ÇalIş, Ü., şumnu,M., HIncal,A.A.,"Colorimetric Determination of A  Novel Antimicrobial Surfactant Mixture (C31G)", 2nd Pharmaceutical Sciencies Meeting, June 11-14  1991, Ankara - Turkey.
  2. ÇALIŞ, S., “Disinfection: Importance and Applications in Human Health", İstanbul Medical Faculty Post-Graduate Symposium and Educational Course, 27-30 September 1995, İstanbul-Turkey. (Invited Lecture) (in Turkish)
  3. HINCAL, A.A., ÇALIŞ, S., "Recent Advances in Controlled Release Systems", Drug Industry and Manufacturers’ Association-Industrial Courses Institute, April 2-4, 1997, İstanbul. (oral presentation)
  4. HINCAL, A.A., KAŞ, H.S., ÇALIŞ, S., “How The World Educates Itself In Medical and Pharmaceutical Field”, Health Sciences Institute Days, May 22-23, 1997, Gaziantep.
  5. HINCAL, A.A., KAŞ, H.S., ÇALIŞ, S., “How The World Educates Itself In Medical and Pharmaceutical Field”, The Poster Exhibition of Announcements of Various International Meetings, 22 September-10 October, 1997, Ankara.
  6. YENİCE, İ., ÇALIŞ, S., ÇAPAN, Y., HINCAL, A.A., "Quality Control of Conventional and Controlled-Release Carbamazepine Tablets" 6th Science and Technology Symposium (with International Participation) (BİOMED-6), October 6-8, 1999, Bornova-İzmir. 
  7. ÇALIŞ, S. “Ulusal Yayıncılığımız ve Türk Tıp Dizini Kriterleri”, Sağlık Bilimlerinde Süreli Yayıncılık 2005 – 3. Ulusal Sempozyum, s.285-290, April 8-9, 2005, TÜBİTAK-Ankara. (In Turkish)
  8. ÇALIŞ, S. “Implantation of Antibiotic Impregnated Allografts and Biopolymeric Microparticles to Infected Bone Defects and Determination of Their Efficiency”, Hacettepe University "Bilim, Düşün, Sanat Şenliği" October 4-6 2005, Hacettepe University-Ankara.
  9. OZLU, E., ÇALIŞ, S., KILIC, M.A. “Developing a Protein-Based Targeted Drug Delivery System for Cancer Therapy: Ferritin-Doxorubicin Complex” Proteomics-Protein Structure and Function Workshop, September 20-23, 2006, Antalya-Turkey.
  10. KAYNAROĞLU, V., ÇAKMAK, A., BİLENSOY, E., ÇIRPANLI, Y., SARIBA޸ Z., ÇALIS¸ S., HASÇELİK, G., YORGANCI, K., “ The Effect of Triclosan Coated Graft on Hernia Graft Infection Model”, Hacettepe University Exhibition of R&D Projects, May 10-11, 2010, Hacettepe University-Ankara. (In Turkish)
  11. ÇALIŞ, S., “İlaç-Tıbbi Cihaz Kombinasyonları”TÜFTAD, “Tıbbi Cihazlar: Ürün Geliştirme, Regülasyonlar ve Klinik Uygulamalar” July 4, 2012, Ankara. (In Turkish)

 

Sema Çalış

Professor

 

  • : 0 (312) 310 15 24
  • : 0 (312) 310 09 06
  • DEPARTMENTDepartment of Pharmaceutical Technology, Faculty of Pharmacy,
    University of Hacettepe
  • COUNTRY Turkey